Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

Conference

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois
Conference

ACCP Annual Meeting

September 14 - 16, 2025 – Phoenix, Arizona – Booth #4
Conference

Arena Clinical Data Management

September 17 - 18, 2025

All late clinical resources

Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus

Certara Products - Pinnacle 21, Data Standards, SDTM, Blog

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

Biologics, Certara Products - Simcyp, Modeling and Simulation - QSP, Press Coverage

De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator

Certara Products, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Webinar

Understanding Antibody-Drug Conjugates (ADCs) Pharmacokinetics From NCA to Population PK Approaches

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Webinar

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara Products, Certara Services, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Blog

Recapping a record-breaking 2025 Krakow HTA Symposium

event, Late clinical - blog, Modeling and Simulation, Blog

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Case Study

AusBiotech International Conference 2025

Certara Products - Phoenix, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Modeling and Simulation, Conference

AAPS 2025 PharmSci 360

Modeling and Simulation, Conference

ADNCA Explained: The Next Generation of Non-Compartmental Analysis and the Top Questions Answered

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.